| Financial Year |
March 31 2023 |
| Monetary Funds |
185,986,916.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
27,833,914.44 |
| Advances to Suppliers |
20,540,006.60 |
| Other Receivables |
332,052,749.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,306,212.46 |
| Dividend Receivable |
-- |
| Inventories |
249,472,642.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
99,651,636.16 |
| Total Current Assets |
915,537,865.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
104,709,969.24 |
| Investment Properties |
36,909,097.14 |
| Fixed Assetes |
1,634,799,435.99 |
| Under-construction Projects |
628,144,043.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
756,224,920.00 |
| R&D expenses |
-- |
| Goodwill |
62,948,918.97 |
| Long-Term Deferred and Prepaid Expenses |
556,745,750.55 |
| Deferred Income Tax Assets |
598,421.92 |
| Other Non-Current Assets |
104,679,915.86 |
| Sub-Total of Non-Current Assets |
4,126,021,164.83 |
| Total Assets |
5,041,559,030.52 |
| Short-Term Loans |
390,967,076.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
41,874,857.00 |
| Accounts Payable |
271,225,292.62 |
| Accounts Received In Advance |
16,600.00 |
| Employee Compensation Payable |
46,224,713.46 |
| Taxes Payable |
10,938,602.78 |
| Interest Payable |
2,118,996.82 |
| Dividend Payable |
-- |
| Other payables |
184,693,462.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
408,819,514.69 |
| Other Current Liabilities |
14,065,319.85 |
| Sub-Total of Current Liabilities |
1,864,492,563.29 |
| Long-term Loans |
298,115,181.64 |
| Bonds Payable |
91,235,756.78 |
| Long-Term Accounts Payable |
212,774,901.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,616,689.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
834,934,173.32 |
| Total Liabilities |
2,699,426,736.61 |
| Paid-In Capital(Or Share Stock) |
720,745,205.00 |
| Capital Surplus |
725,865,613.81 |
| Surplus Reserve |
285,854,078.82 |
| LESS:Treasury Stock |
230,957,278.02 |
| Undistributed Profits |
580,155,703.89 |
| Minority Stockholder's Interest |
246,547,416.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,095,584,877.18 |
| Owner's Equity（Stockholder's Equity） |
2,342,132,293.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,041,559,030.52 |
